Opposing actions of endocannabinoids on cholangiocarcinoma growth is via the differential activation of Notch signaling.
about
Recent advances in the regulation of cholangiocarcinoma growthIncreasing antiproliferative properties of endocannabinoids in N1E-115 neuroblastoma cells through inhibition of their metabolism.The association of N-palmitoylethanolamine with the FAAH inhibitor URB597 impairs melanoma growth through a supra-additive action.Recent advances in the understanding of the role of the endocannabinoid system in liver diseases.RNAi-mediated inhibition of presenilin 2 inhibits glioma cell growth and invasion and is involved in the regulation of Nrg1/ErbB signaling.The endocannabinoid, anandamide, augments Notch-1 signaling in cultured cortical neurons exposed to amyloid-β and in the cortex of aged ratsBile Acid Signaling Is Involved in the Neurological Decline in a Murine Model of Acute Liver Failure.The potential relevance of the endocannabinoid, 2-arachidonoylglycerol, in diffuse large B-cell lymphoma.Orphan G protein receptor GPR55 as an emerging target in cancer therapy and management.Update on the endocannabinoid system as an anticancer target.Endothelial-to-hematopoietic transition: Notch-ing vessels into blood.Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA).Anandamide-induced endoplasmic reticulum stress and apoptosis are mediated by oxidative stress in non-melanoma skin cancer: Receptor-independent endocannabinoid signaling.Anandamide exerts its antiproliferative actions on cholangiocarcinoma by activation of the GPR55 receptor.
P2860
Q33994814-D53822F6-AF45-46EF-B857-A4F1FDF0AC72Q34064728-9D5F3EB8-87F1-475A-B619-538D1959AEB5Q34202076-AF894BE2-A7A5-4F96-86DA-5DB8DFE0447BQ34550846-98A8767B-9CD9-426B-8B2B-693CA8F198C0Q36127451-30544455-4CA3-4EB9-8998-BD6FB630D8ACQ36298496-4A7018F0-EE19-4033-A4EF-62ED9871264AQ36509199-32BDB301-9E90-4052-AB38-9165B01C46E2Q36575297-44AF1B26-28F5-47D1-B581-B2BF9712B0CBQ36996563-1B4D015E-6802-4F6D-BF7B-9AF9E8B9CA9BQ37829751-110141FC-7F62-4E60-83DE-1BF73975EA75Q38789096-E41F4AB1-3610-468E-BE0A-5B83904B7548Q38812588-1D5CB0EB-3C93-4E7F-B3A2-D43CB07B7DB3Q38823998-F11F3816-EA28-4729-AB93-9329AEF7C0AAQ39564556-353B60AA-7B88-470F-8E31-282200AA4E35
P2860
Opposing actions of endocannabinoids on cholangiocarcinoma growth is via the differential activation of Notch signaling.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Opposing actions of endocannab ...... activation of Notch signaling.
@en
type
label
Opposing actions of endocannab ...... activation of Notch signaling.
@en
prefLabel
Opposing actions of endocannab ...... activation of Notch signaling.
@en
P2093
P2860
P1476
Opposing actions of endocannab ...... activation of Notch signaling.
@en
P2093
Gabriel Frampton
Jonathan Ramirez
Monique Coufal
Sharon DeMorrow
P2860
P304
P356
10.1016/J.YEXCR.2010.03.017
P407
P577
2010-03-25T00:00:00Z